Onclive articles Copyright (c) 2015 Intellisphere, LLC. All rights reserved. http://www.onclive.com/articles Onclive articles Onclive articles en-us Tue, 24 May 2016 11:55:57 UTC 5 Onclive articles 144 47 http://www.onclive.com/articles http://www.onclive.com/media/image/35ab4bcc0544887940a968b55494cbb1.jpg <![CDATA[Frontline Cabozantinib Improves PFS in Renal Cell Carcinoma]]>http://www.onclive.com/web-exclusives/frontline-cabozantinib-improves-pfs-in-renal-cell-carcinomaOnclive articlesusMon, 23 May 2016 19:45:35 UTCOnclive<![CDATA[Daratumumab Approved in Europe for Multiple Myeloma]]>http://www.onclive.com/web-exclusives/daratumumab-approved-in-europe-for-multiple-myelomaOnclive articlesusMon, 23 May 2016 16:48:43 UTCOnclive<![CDATA[Role of Radiation Therapy Evolves for Elderly Patients With Breast Cancer]]>http://www.onclive.com/web-exclusives/expert-shares-the-evolving-role-of-radiation-therapy-for-elderly-patients-with-breast-cancerOnclive articlesusMon, 23 May 2016 13:53:01 UTCOnclive<![CDATA[IHC Staining Found Effective for ROS1+ NSCLC]]>http://www.onclive.com/web-exclusives/ihc-staining-found-effective-for-ros1-nsclcOnclive articlesusSun, 22 May 2016 13:00:24 UTCOnclive<![CDATA[High Genomic Classifier Score Increases Risk of Dying From Prostate Cancer]]>http://www.onclive.com/publications/urologists-in-cancer-care/2016/June-2016/high-genomic-classifier-score-increases-risk-of-dying-from-prostate-cancerOnclive articlesusSat, 21 May 2016 13:00:08 UTCOnclive<![CDATA[Retreatment With Radium-223 Found Safe in mCRPC]]>http://www.onclive.com/web-exclusives/retreatment-with-radium223-found-safe-in-mcrpcOnclive articlesusFri, 20 May 2016 21:07:41 UTCOnclive<![CDATA[FDA Grants CPX-351 Breakthrough Designation for AML]]>http://www.onclive.com/web-exclusives/fda-grants-cpx351-breakthrough-designation-for-amlOnclive articlesusFri, 20 May 2016 20:09:16 UTCOnclive<![CDATA[Lead NeoSphere Author Discusses Pertuzumab Update in HER2+ Breast Cancer]]>http://www.onclive.com/web-exclusives/lead-neosphere-author-discusses-pertuzumab-update-in-her2-breast-cancerOnclive articlesusFri, 20 May 2016 15:28:58 UTCOnclive<![CDATA[Expert Discusses Treatment Trends in HER2+ Breast Cancer]]>http://www.onclive.com/web-exclusives/expert-discusses-treatment-trends-in-her2-breast-cancerOnclive articlesusFri, 20 May 2016 14:34:04 UTCOnclive<![CDATA[Second Daratumumab Triplet Delays Disease Progression in Myeloma]]>http://www.onclive.com/web-exclusives/second-daratumumab-triplet-delays-disease-progression-in-myelomaOnclive articlesusThu, 19 May 2016 20:42:52 UTCOnclive